Abstract
Overstimulation of pro-proliferative pathways and high level expression of pro-proliferative transcription factors (TFs) can lead to apoptosis. This is likely due to TF binding sites for pro-proliferative TFs common to pro-proliferative and pro-apoptosis-effector genes. Certain clinical datasets have indicated that molecular markers associated with higher proliferation rates lead to improved outcomes for patients with cancer. These observations have been extensively assessed on a general basis, however there has been little work dissecting feed-forward apoptosis signaling pathways that may represent specific distinctions between a pro-proliferative mechanism and a pro-apoptotic mechanism in samples from patients with cancer. Using The Cancer Genome Atlas datasets and bioinformatic approaches, the present study reports that higher FOS expression levels, along with higher FOS target apoptosis-effector gene expression, is associated with an increased survival, while higher POU2F1 expression is associated with a reduced survival (average difference of 25.9 months survival). In summary, in the datasets examined FOS represents an apoptosis-driver and high POU2F1 represents a driver mechanism for cancer development.
References
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·X Wu, A J Levine
May 1, 1996·Molecular and Cellular Biology·F OswaldM Lipp
May 17, 1996·Cell·L YamasakiN J Dyson
May 17, 1996·Cell·S J FieldM E Greenberg
Sep 15, 1996·Cellular Immunology·J P TrumanN Mooney
May 10, 2000·Nature Medicine·T TeitzV J Kidd
Jan 18, 2003·DNA Repair·Bruce C McKayMats Ljungman
Mar 17, 2004·Current Opinion in Immunology·Fernando MaciánAnjana Rao
Jun 12, 2010·Immunological Reviews·Judy Lieberman
Sep 23, 2011·Cell Cycle·Huarui LuTimothy C Hallstrom
May 17, 2012·Cancer Discovery·Ethan CeramiNikolaus Schultz
Jul 9, 2013·The Journal of Biological Chemistry·Huarui Lu, Timothy C Hallstrom
Dec 3, 2013·Gene·James A Mauro, George Blanck
Sep 23, 2014·Experimental and Molecular Pathology·Karoly SzekeresGeorge Blanck
Oct 14, 2014·Gene·James A MauroGeorge Blanck
Dec 3, 2014·Biochimica Et Biophysica Acta·Shea A Ford, George Blanck
May 7, 2015·Cell Cycle·Marlene GarciaGeorge Blanck
Jun 30, 2016·Cell Cycle·John M Yavorski, George Blanck
Jan 1, 2017·Physiological Reports·John M Yavorski, George Blanck
Mar 5, 2017·Gene·James A MauroGeorge Blanck
Oct 20, 2017·International Journal of Cancer. Journal International Du Cancer·Blake M CallahanGeorge Blanck
Jan 7, 2018·Journal of Cancer Research and Clinical Oncology·Dhiraj SikariaGeorge Blanck